138 related articles for article (PubMed ID: 24608884)
1. Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation.
Carvalho C; Siegel D; Inman M; Xiong R; Ross D; Moody CJ
Org Biomol Chem; 2014 May; 12(17):2663-74. PubMed ID: 24608884
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors.
Tanaka M; Li X; Hikawa H; Suzuki T; Tsutsumi K; Sato M; Takikawa O; Suzuki H; Yokoyama Y
Bioorg Med Chem; 2013 Mar; 21(5):1159-65. PubMed ID: 23337802
[TBL] [Abstract][Full Text] [Related]
3. Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.
Serra S; Moineaux L; Vancraeynest C; Masereel B; Wouters J; Pochet L; Frédérick R
Eur J Med Chem; 2014 Jul; 82():96-105. PubMed ID: 24878638
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of the Reported Pyranonaphthoquinone Structure of the Indoleamine-2,3-dioxygenase Inhibitor Annulin B by Regioselective Diels-Alder Reaction.
Inman M; Carvalho C; Lewis W; Moody CJ
J Org Chem; 2016 Sep; 81(17):7924-30. PubMed ID: 27513176
[TBL] [Abstract][Full Text] [Related]
5. Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.
Markwalder JA; Seitz SP; Blat Y; Elkin L; Hunt JT; Pabalan JG; Jure-Kunkel MN; Vite GD; Covello K
Bioorg Med Chem Lett; 2017 Feb; 27(3):582-585. PubMed ID: 28003141
[TBL] [Abstract][Full Text] [Related]
6. Marine natural products and other derivatives as potent indoleamine 2,3-dioxygenase inhibitors.
Delfourne E
Mini Rev Med Chem; 2012 Sep; 12(10):988-96. PubMed ID: 22512584
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.
Huang Q; Zheng M; Yang S; Kuang C; Yu C; Yang Q
Eur J Med Chem; 2011 Nov; 46(11):5680-7. PubMed ID: 21925773
[TBL] [Abstract][Full Text] [Related]
9. Rational design of indoleamine 2,3-dioxygenase inhibitors.
Röhrig UF; Awad L; Grosdidier A; Larrieu P; Stroobant V; Colau D; Cerundolo V; Simpson AJ; Vogel P; Van den Eynde BJ; Zoete V; Michielin O
J Med Chem; 2010 Feb; 53(3):1172-89. PubMed ID: 20055453
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents.
Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L
Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy.
Yentz S; Smith D
BioDrugs; 2018 Aug; 32(4):311-317. PubMed ID: 29980987
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic synthesis of the IDO inhibitors exiguamine A and B.
Volgraf M; Lumb JP; Brastianos HC; Carr G; Chung MK; Münzel M; Mauk AG; Andersen RJ; Trauner D
Nat Chem Biol; 2008 Sep; 4(9):535-7. PubMed ID: 18677305
[TBL] [Abstract][Full Text] [Related]
14. Research progress of indoleamine 2,3-dioxygenase inhibitors.
Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
[TBL] [Abstract][Full Text] [Related]
15. Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Williams DK; Markwalder JA; Balog AJ; Chen B; Chen L; Donnell J; Haque L; Hart AC; Mandal SK; Nation A; Shan W; Vite GD; Covello K; Hunt JT; Jure-Kunkel MN; Seitz SP
Bioorg Med Chem Lett; 2018 Feb; 28(4):732-736. PubMed ID: 29398543
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors.
Dong J; Pan X; Yang Y; Zhang G; Xiao Z; Liu Z
Eur J Med Chem; 2021 Nov; 223():113631. PubMed ID: 34147748
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 4- and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase.
Balti M; Plas A; Meinguet C; Haufroid M; Thémans Q; Efrit ML; Wouters J; Lanners S
Bioorg Med Chem Lett; 2017 Aug; 27(15):3607-3610. PubMed ID: 28651980
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Intracellular Redox Cycling of Natural Quinones and Their Analogues and Identification of Indoleamine-2,3-dioxygenase (IDO) as Potential Target for Anticancer Activity.
Blunt CE; Torcuk C; Liu Y; Lewis W; Siegel D; Ross D; Moody CJ
Angew Chem Int Ed Engl; 2015 Jul; 54(30):8740-5. PubMed ID: 26096359
[TBL] [Abstract][Full Text] [Related]
19. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
Lancellotti S; Novarese L; De Cristofaro R
Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
[TBL] [Abstract][Full Text] [Related]
20. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
